Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker

scientific article published in November 2002

Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1124/MOL.62.5.1228
P698PubMed publication ID12391287
P5875ResearchGate publication ID277547483

P50authorChung-chin KuoQ43190242
P2093author name stringYa-Chin Yang
P433issue5
P304page(s)1228-1237
P577publication date2002-11-01
P1433published inMolecular PharmacologyQ1943386
P1476titleInhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker
P478volume62

Reverse relations

cites work (P2860)
Q33918510A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia
Q30441260A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profile
Q38040330Advances in targeting voltage-gated sodium channels with small molecules
Q36412627An inactivation stabilizer of the Na+ channel acts as an opportunistic pore blocker modulated by external Na+.
Q48308933Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation
Q41668278Bupivacaine blocks N-type inactivating Kv channels in the open state: no allosteric effect on inactivation kinetics
Q46199353Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential.
Q36410736Epileptic consciousness: concept and meaning of aura.
Q42931956Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating.
Q35122828Inhibition of neuronal voltage-gated sodium channels by brilliant blue G
Q41952692Mechanism of block of hEag1 K+ channels by imipramine and astemizole
Q35545122Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels
Q35574947Pharmacogenomics in the treatment of epilepsy
Q44683069Potentiation of imipramine-induced antinociception by nicotine in the formalin test
Q39380930Quantitative modelling of interaction of propafenone with sodium channels in cardiac cells
Q38825019Role of Sodium Channels in Epilepsy
Q42088430SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs
Q42080376Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide
Q48274837State-dependent block of voltage-gated sodium channels by the casein-kinase 1 inhibitor IC261.
Q30866710State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agents
Q48875355The antidepressant citalopram inhibits delayed rectifier outward K⁺ current in mouse cortical neurons.
Q34352436The block of CFTR by scorpion venom is state-dependent
Q37280509The external pore loop interacts with S6 and S3-S4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the Na(+) channel
Q24606139The young brain and concussion: imaging as a biomarker for diagnosis and prognosis
Q40444942V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels
Q48666406Voltage-gated Na+ channel ligands and ATP: relative molecular similarity and implications for channel function

Search more.